|
1.Name of the securities: CHINA CHEMICAL & PHARMACEUTICAL CO., LTD.
2.Trading date: 2018/10/08~2019/03/27
3.Trading volume, unit price, and total monetary amount of the transaction:
Trading volume: 8,199,000 shares;
Unit price: Average price NT$ 19.00 per share;
Total monetary amount: NT$ 155,784,715 (including related taxes and expenses)
4.Gain (or loss) (not applicable in case of acquisition of securities): NA
5.Relationship with the underlying company of the trade:
CCSB is the Company's investment using the equity method of accounting.
6.Current cumulative volume, amount, and shareholding percentage of holdings of the security being traded (including the current trade) and status of any restriction of rights (e.g.pledges):
Current cumulative volume：20,983,137 shares
Amount：NT$422,219,178
Shareholding percentage of holdings of the security being traded (including the current trade)：7.04 %
Status of any restriction of rights：None
7.Current ratio of long or short term securities investment (including the current trade) to the total assets and shareholder's equity as shown in the most recent financial statement and the operational capital as shown in the most recent financial statement:
Ratio to the total assets: 12.91 %
Ratio to the shareholder's equity: 21.63 %
Operational capital: NT$ 157,475 thousand
8.Concrete purpose/objective of the acquisition or disposal: Investment
9.Do the directors have any objections to the present transaction?: No
10.Is it a related party transaction?: No
11.Counterparty to the trade and its relationship to the company: NA
12.Date of the board of directors' resolution: 2018/10/01
13.Date of the recognition of the supervisors or the board of independent directors' resolution: 2018/10/01
14.Any other matters that need to be specified: None
|
